The company is preparing to apply for emergency authorization from the Food and Drug Administration. But the shot may not be needed in the United States. By Rebecca Robbins and Benjamin Mueller from NYT Business https://ift.tt/3vKKb4m
The company is preparing to apply for emergency authorization from the Food and Drug Administration. But the shot may not be needed in the United States. By Rebecca Robbins and Benjamin Mueller from NYT Business https://ift.tt/3vKKb4m